サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1225589

脳卒中管理の世界市場－成長、将来展望、競合分析（2023年～2031年）

Stroke Management Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
脳卒中管理の世界市場－成長、将来展望、競合分析（2023年～2031年）
出版日: 2023年01月23日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳卒中の診断率の上昇、技術的進歩の上昇は、市場の成長を促進しています。しかし、高い治療費と新しい高度な診断技術を承認するための厳しい政府の方針が、この市場の成長を抑制する可能性があります。

当レポートでは、世界の脳卒中管理市場について調査分析し、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
    • レポートの目的
    • 対象者
    • 主な製品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ－2次調査
    • フェーズⅡ－1次調査
    • フェーズⅢ－専門家による審査
    • 仮定
    • 採用されたアプローチ

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の脳卒中管理市場
  • 世界の脳卒中管理市場（100万米ドル）（2022年）：製品別
  • 世界の脳卒中管理市場（100万米ドル）（2022年）：用途別
  • 世界の脳卒中管理市場（100万米ドル）（2022年）：地域別
  • 魅力的な投資提案（2022年）：地域別

第3章 脳卒中管理市場：競合分析

  • 主要な脳卒中管理市場ベンダーの市場ポジショニング
  • 脳卒中管理市場のベンダーが採用する戦略
  • 主要な業界戦略
  • 階層分析2022年と2031年の比較

第4章 脳卒中管理市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の脳卒中管理市場金額（100万米ドル）（2021年～2031年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 脳卒中管理市場、米ドル（100万）（2021年～2031年）：製品別

  • 市場概要
  • 成長と収益分析：2022年と2031年の比較
  • 市場セグメンテーション
    • 診断
    • 治療

第6章 脳卒中管理市場、米ドル（100万）（2021年～2031年）：用途別

  • 市場概要
  • 成長と収益分析：2022年と2031年の比較
  • 市場セグメンテーション
    • 虚血性脳卒中
    • 出血性脳卒中

第7章 北米の脳卒中管理市場、米ドル（100万）（2021年～2031年）

第8章 英国および欧州連合の脳卒中管理市場、米ドル（100万）（2021年～2031年）

第9章 アジア太平洋の脳卒中管理市場、米ドル（100万）（2021年～2031年）

第10章 ラテンアメリカの脳卒中管理市場、米ドル（100万）（2021年～2031年）

第11章 中東およびアフリカの脳卒中管理市場、米ドル（100万）（2021年～2031年）

第12章 企業プロファイル

  • B Braun Melsungen AG
  • Abbott Laboratories
  • Boston Scientific Corp,
  • Medtronic Plc.
  • Bristol-Myers Squibb
  • Cardinal Health
  • Siemens Healthcare
  • GE Healthcare
  • Merck & Company
  • GlaxoSmithKline Plc.
  • その他
図表

List of Tables

  • TABLE 1 Global Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 3 Global Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 4 Global Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 5 North America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 6 North America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 7 North America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 8 North America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 10 U.S. Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 11 U.S. Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 12 U.S. Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 13 Canada Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Canada Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 15 Canada Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 16 Canada Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 25 UK Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 26 UK Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 27 UK Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 28 UK Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Germany Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 30 Germany Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 31 Germany Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 32 Germany Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 33 Spain Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 34 Spain Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 35 Spain Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 36 Spain Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 37 Italy Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Italy Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 39 Italy Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 40 Italy Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 41 France Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 42 France Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 43 France Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 44 France Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 49 Asia Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Asia Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 51 Asia Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 52 Asia Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 53 China Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 54 China Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 55 China Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 56 China Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Japan Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 58 Japan Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 59 Japan Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 60 Japan Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 61 India Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 62 India Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 63 India Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 64 India Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 65 Australia Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 66 Australia Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 67 Australia Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 68 Australia Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 69 South Korea Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 70 South Korea Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 71 South Korea Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 72 South Korea Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 73 Latin America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Latin America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 75 Latin America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 76 Latin America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 77 Brazil Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 78 Brazil Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 79 Brazil Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 80 Brazil Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 81 Mexico Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 82 Mexico Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 83 Mexico Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 84 Mexico Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 93 GCC Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 94 GCC Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 95 GCC Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 96 GCC Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 97 Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 98 Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 99 Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 100 Africa Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Stroke Management Market By Application, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Stroke Management Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Stroke Management Market: Quality Assurance
  • FIG. 5 Global Stroke Management Market, By Product, 2022
  • FIG. 6 Global Stroke Management Market, By Application, 2022
  • FIG. 7 Global Stroke Management Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Stroke Management Market, 2022
  • FIG. 9 Market Positioning of Key Stroke Management Market Players, 2022
  • FIG. 10 Global Stroke Management Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Stroke Management Market, By Product, 2022 Vs 2031, %
  • FIG. 12 Global Stroke Management Market, By Application, 2022 Vs 2031, %
  • FIG. 13 U.S. Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 20 France Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 22 China Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 24 India Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Stroke Management Market (US$ Million), 2021 - 2031
目次
Product Code: 138176-01-23

Stroke is predominantly observed among the geriatric population and is globally considered as a major cause of death. The rise in adoption of unhealthy lifestyle patterns, alcohol and smoking addiction has collectively contributed to the rise in prevalence of stroke. As per the America Medical Association, around 40% of geriatric population (aged 55 and above) of U.S. suffer from stroke. The World Health Organization estimates around 17 million deaths due to stroke annually. According to the Centers for Disease Control and Prevention, around 0.7 million individuals in the U.S. suffer from stroke each year. The rise in prevalence of stroke fuels the overall market growth. The stroke management market is analysed by segmenting the market into type of products, application and geography. The products are further classified into diagnostic and therapeutic products.

The growing awareness among individuals and healthcare professionals play an important role in the growth of this market. The rise in awareness has led to the increase in diagnosis rate of stroke, thus accounted for its maximum market share in 2022. With the rise in technological advancements and with patients considering preventive diagnosis, the diagnostic segment would also attain fastest CAGR during the forecast period. The availability of suitable treatment guidelines ensures appropriate treatment thus catalysing the overall stroke management market. The American Heart Association collaborated with the Heart Rhythm Society, the American Academy of Family Physicians and the International Society for Heart & Lung Transplantation to develop guidelines that would aid physicians in appropriate treatment of heart failures. These guidelines provide a foundation for appropriate cardiovascular care. However, high treatment cost and stringent government policies to approve new an advanced diagnostic technologies could intervene with the growth of this market.

Of the various geographical regions analysed, North America held the largest market share in 2022. Asia Pacific projected to grow with fastest CAGR during the forecast period from 2023 to 2031. The North American market growth is predominantly driven by the rise in prevalence of chronic diseases leading to cardiovascular risks, increased disposable income, rise in healthcare expenditure and the constant investments in research and development.

The global stroke management market comprises market players namely B Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corp, Medtronic Plc., Bristol-Myers Squibb, Cardinal Health, , Siemens Healthcare, GE Healthcare, Merck & Company and GlaxoSmithKline Plc.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Stroke Management market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Stroke Management market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Diagnostics

Computed Tomography Scan (CT Scan)

Magnetic Resonance Imaging (MRI)

Carotid Ultrasound

Cerebral Angiography

Electrocardiography

Echocardiography

Other diagnostics

Therapeutics

Tissue Plasminogen Activator

Anticoagulant

Antiplatelet

Antihypertensive

Application

Ischemic Stroke

Haemorrhagic Stroke

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2021-2022; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Stroke Management market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Stroke Management market?

Which is the largest regional market for Stroke Management market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Stroke Management market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Stroke Management market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Stroke Management Market
  • 2.2. Global Stroke Management Market, By Product, 2022 (US$ Million)
  • 2.3. Global Stroke Management Market, By Application, 2022 (US$ Million)
  • 2.4. Global Stroke Management Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Stroke Management Market: Competitive Analysis

  • 3.1. Market Positioning of Key Stroke Management Market Vendors
  • 3.2. Strategies Adopted by Stroke Management Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Stroke Management Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Stroke Management Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Stroke Management Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Diagnostics
      • 5.3.1.1. Computed Tomography Scan (CT Scan)
      • 5.3.1.2. Magnetic Resonance Imaging (MRI)
      • 5.3.1.3. Carotid Ultrasound
      • 5.3.1.4. Cerebral Angiography
      • 5.3.1.5. Electrocardiography
      • 5.3.1.6. Echocardiography
      • 5.3.1.7. Other diagnostics
    • 5.3.2. Therapeutics
      • 5.3.2.1. Tissue Plasminogen Activator
      • 5.3.2.2. Anticoagulant
      • 5.3.2.3. Antiplatelet
      • 5.3.2.4. Antihypertensive

6. Stroke Management Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Ischemic Stroke
    • 6.3.2. Haemorrhagic Stroke

7. North America Stroke Management Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 7.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 7.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Stroke Management Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 8.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 8.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.4.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.5.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.6.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Stroke Management Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 9.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 9.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.4.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.5.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.6.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

10. Latin America Stroke Management Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 10.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 10.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Stroke Management Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 11.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 11.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. B Braun Melsungen AG
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Abbott Laboratories
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Boston Scientific Corp,
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Medtronic Plc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Bristol-Myers Squibb
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Cardinal Health
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Siemens Healthcare
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. GE Healthcare
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Merck & Company
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. GlaxoSmithKline Plc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Others
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives